Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name MK-1308A
Trade Name
Synonyms Pembrolizumab/Quavonlimab|MK1308A|MK 1308A
Drug Descriptions

Limited information is currently available on MK-1308A, a coformulation of Pembrolizumab and Quavonlimab (Oct 2021).

DrugClasses CTLA4 Antibody 21 Immune Checkpoint Inhibitor 135 PD-L1/PD-1 antibody 79
CAS Registry Number NA


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Lenvatinib + MK-1308A Lenvatinib MK-1308A 0 5
MK-1308A MK-1308A 0 3
MK-1308A + MK-4830 MK-1308A MK-4830 0 1

Additional content available in CKB BOOST